Why Did the CEO of UAMY Buy Stock Immediately After Visiting the White House?
Why Gary Evans is committing personal capital to North America's primary antimony processor amidst rising defense supply concerns.

Washington policymakers and defense officials are finding out the hard way that modern high-tech weaponry is virtually useless without a specific, obscure metalloid.
When corporate leaders spend their mornings in White House briefings and their afternoons buying up their own company's stock, Wall Street takes notice. Gary Evans, Chairman and CEO of United States Antimony Corporation (NYSE: UAMY), has been walking those exact federal halls while backstopping his strategy with personal capital.
According to official filings with the U.S. Securities and Exchange Commission, Evans executed an open-market purchase of 20,000 shares of United States Antimony Corporation (NYSE: UAMY) on August 28, 2026, at $4.92 per share. The transaction brought his direct ownership to 2,590,028 shares, capping off a twelve-month stretch where he accumulated over 120,000 shares without making a single insider sale. When an executive commits roughly $700,000 of personal liquidity into an industrial micro-cap, it serves as a vote of confidence that quarterly presentations rarely match.




